---
title: "JOINN Laboratories Announces Governance Amendments Ahead of Legal Changes"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263563581.md"
description: "JOINN Laboratories (China) Co., Ltd. has announced amendments to its Articles of Association and general meeting procedures in response to upcoming changes in the Company Law of China, effective July 1, 2024. Key changes include adjusting the board of directors and eliminating the supervisory committee, aimed at enhancing governance and compliance. The current analyst rating for JOINN Laboratories (HK:6127) is a Hold with a price target of HK$16.30. The company operates in the biotechnology and pharmaceutical sector, focusing on laboratory services and drug development support."
datetime: "2025-10-30T15:14:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263563581.md)
  - [en](https://longbridge.com/en/news/263563581.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263563581.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263563581.md) | [English](https://longbridge.com/en/news/263563581.md)


# JOINN Laboratories Announces Governance Amendments Ahead of Legal Changes

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an update.

JOINN Laboratories (China) Co., Ltd. has announced proposed amendments to its Articles of Association and the rules of procedures for its general meeting of shareholders. These changes are in response to the upcoming amendments to the Company Law of the People’s Republic of China, effective from July 1, 2024. The key amendments include altering the number of directors on the board and removing the supervisory committee, aligning with legal and regulatory updates. These changes are expected to impact the company’s governance structure and could influence its operational efficiency and compliance with new legal standards.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

**More about JOINN Laboratories (China) Co., Ltd. Class H**

JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the biotechnology and pharmaceutical industry, focusing on providing laboratory services and research support for drug development and testing.

**Average Trading Volume:** 6,769,040

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$26.27B

For an in-depth examination of 6127 stock, go to TipRanks’ Overview page.

### 相關股票

- [JOINN (603127.CN)](https://longbridge.com/zh-HK/quote/603127.CN.md)
- [JOINN (06127.HK)](https://longbridge.com/zh-HK/quote/06127.HK.md)

## 相關資訊與研究

- [Pop Mart’s $33 Billion Rout Casts Doubt on Life After Labubu](https://longbridge.com/zh-HK/news/281434908.md)
- [22:00 ETHEARTS ON FIRE CELEBRATES 30 YEARS OF BRILLIANCE WITH NEW GLOBAL CAMPAIGN WHAT'S YOUR SIGNATURE?](https://longbridge.com/zh-HK/news/281450272.md)
- [08:54 ETNew Research Claims to Show Bioavailability of Oral Liposomal Glutathione. But does it really?](https://longbridge.com/zh-HK/news/281371900.md)
- [Uber increases stake in WeRide as robotaxi partnership ramps up in Dubai](https://longbridge.com/zh-HK/news/281219301.md)
- [00:50 ETLas ventas de "Children of the Sun" de Jay Chou han superado los 100 millones de RMB](https://longbridge.com/zh-HK/news/280956359.md)